Ļć½¶ŹÓʵ

Manish Kohli
( out of 43 reviews )

Manish Kohli, MD

  • Dr. Manish Kohli graduated in 1990 from the Ļć½¶ŹÓʵ of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the Ļć½¶ŹÓʵ of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the Ļć½¶ŹÓʵ of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined Ļć½¶ŹÓʵ of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-Ļć½¶ŹÓʵ of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the Ļć½¶ŹÓʵ of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on ā€œconvergence sciencesā€ which combines population based trials with precision medicine concepts.

    Patient Rating

    4.9 /5
    ( out of 43 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 27, 2024
    HUNTSMAN CANCER CENTER

    Dr. Kohli is an experienced oncologist. He is easy to talk with, he listens carefully and he has our confidence.

    September 06, 2024
    HUNTSMAN CANCER CENTER

    Thank you Dr. Kohli for your professional treatment and always preparing for our visit by reviewing all my information before each office visit. Your team is always prepared.

    July 05, 2024
    HUNTSMAN CANCER CENTER

    How would you recommend him to any patient that has cancer?He does a great job

    June 07, 2024
    HUNTSMAN CANCER CENTER

    He's just a very rarely good he cares about the patience very well I would recommend him to others

    May 25, 2024
    HUNTSMAN CANCER CENTER

    Very professional and carring

    May 17, 2024
    HUNTSMAN CANCER CENTER

    Best Doctor and staff, best ever

    May 06, 2024
    HUNTSMAN CANCER CENTER

    Muy paciente y explica todo con eficiencia.

    April 19, 2024
    HUNTSMAN CANCER CENTER

    Great, caring doctor

    April 06, 2024
    HUNTSMAN CANCER CENTER

    Friendly, caring and competent

    See More Patient Comments

  • Dr. Manish Kohli graduated in 1990 from the Ļć½¶ŹÓʵ of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the Ļć½¶ŹÓʵ of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the Ļć½¶ŹÓʵ of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined Ļć½¶ŹÓʵ of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-Ļć½¶ŹÓʵ of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the Ļć½¶ŹÓʵ of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on ā€œconvergence sciencesā€ which combines population based trials with precision medicine concepts.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Oncology

  • News & Podcasts

    Huntsman Cancer Institute News